Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 D3 pseudogene 4 (UBE2D3P4)

Target
UBE2D3P4
Molecular classification
Other (Pseudogene), Not an enzyme, receptor, transporter or other classic molecular target family
01

Overview

Ubiquitin conjugating enzyme E2 D3 pseudogene 4 (UBE2D3P4) is a human pseudogene located on chromosome 13q31[3]. It is a non-functional, genomic copy related to the UBE2D3 gene, which encodes an E2 ubiquitin-conjugating enzyme involved in protein ubiquitination, but UBE2D3P4 itself does not produce a functional protein, and there is no evidence of physiological or pathophysiological role for this pseudogene. Other pseudogenes in the ubiquitin gene family have been shown to be transcribed or rarely translated into variant proteins, but there is no evidence in the literature or current gene/protein databases for UBE2D3P4 encoding a functional product or having biological or therapeutic relevance[3][5]. Summary judgment: UBE2D3P4 is a non-expressed pseudogene and not a relevant drug target. Caution should be exercised to avoid confusion with the functional parent gene, UBE2D3, which is a research target involved in protein ubiquitination and linked to disease, but is distinct from this pseudogene[2][3][5].

Other names
UBE2D3 pseudogene 4UBE2D3P4
02

Mechanism of action

None (as above, no mechanism because no protein product is produced).

03

Biological functions

None known (as a pseudogene, no protein product or known biological function).
04

Disease associations

None established (no evidence for involvement in disease as a pseudogene).Note: The parent gene, UBE2D3, has documented roles in cancer and other disease contexts[2], but not UBE2D3P4.
05

Safety considerations

None (not a therapeutic target, so no associated pharmacological safety issues).
06

Interacting drugs

None (no current drugs target this pseudogene).
07

Biomarkers

None (not used as a biomarker; could potentially be used in genomics research as a control or genetic marker but not clinically).

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 D3 pseudogene 4 (UBE2D3P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 D3 pseudogene 4 (UBE2D3P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call